Articles published by Agenus

Nature Medicine Reports Agenus’ Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50

June 13, 2024

From Agenus

Via Business Wire

Tickers AGEN

Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update

July 26, 2023

From Agenus

Via Business Wire

Tickers AGEN

ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer

June 30, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus Announces Virtual Annual Shareholders Meeting

June 05, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus to Participate in Jefferies Healthcare Conference

May 25, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI

May 03, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting

April 26, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus to Provide Corporate Update and First Quarter 2023 Financial Report

April 25, 2023

From Agenus

Via Business Wire

Tickers AGEN

Agenus to Participate in May Investor Conferences

April 24, 2023

From Agenus

Via Business Wire

Tickers AGEN

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.